Dopamine D1 Receptors in Cocaine Dependence Measured with PET and the Choice to Self-administer Cocaine

Overview

Journal Neuropsychopharmacology

Date 2009 Jan 30

PMID 19177067

Citations 40

Authors

Diana Martinez

Mark Slifstein

Rajesh Narendran

Richard W Foltin

Allegra Broft

Dah-Ren Hwang

Audrey Perez

Anissa Abi-Dargham

Marian W Fischman

Herbert D Kleber

Marc Laruelle

Affiliations

Soon will be listed here.

Abstract

The goal of this study was to determine D(1) receptor availability in human cocaine-dependent (CD) subjects and matched healthy controls (HCs). In addition, the CD subjects performed cocaine self-administration sessions in order to explore the association between D(1) receptor availability and cocaine-seeking behavior. Twenty-five CD subjects (40+/-4 years, 19M/6 F) and 23 matched HCs (38+/-4 years, 19M/4F) were scanned with PET and the radiotracer [(11)C]NNC 112. During the cocaine self-administration sessions, CD volunteers were given the choice to self-administer cocaine (0, 6, and 12 mg) or to receive a monetary voucher worth $5. D(1) receptor availability was measured in the limbic, associative, and sensori-motor striatum in addition to cortical brain regions. No difference in D(1) receptor availability was seen between the two groups. A negative association was seen between D(1) receptor BP(ND) in the limbic striatum and the choice for the 6 mg dose of cocaine (r=-0.47, p=0.02, corrected for age). These results do not support the hypothesis that cocaine dependence is associated with a reduction in D(1) receptor availability in the striatum. However, within the CD subjects, low D(1) receptor availability in the ventral striatum was associated with the choice to self-administer cocaine, suggesting that low D(1) receptor availability may be associated with an increased risk of relapse in cocaine dependence.

Citing Articles

Co-targeting the kappa opioid receptor and dopamine transporter reduces motivation to self-administer cocaine and partially reverses dopamine system dysregulation.

Estave P, Albertson S, Karkhanis A, Jones S Sci Rep. 2024; 14(1):6509.

PMID: 38499566 PMC: 10948819. DOI: 10.1038/s41598-024-53463-9.

Are There Prevalent Sex Differences in Psychostimulant Use Disorder? A Focus on the Potential Therapeutic Efficacy of Atypical Dopamine Uptake Inhibitors.

Hersey M, Bartole M, Jones C, Newman A, Tanda G Molecules. 2023; 28(13).

PMID: 37446929 PMC: 10343811. DOI: 10.3390/molecules28135270.

Altered prefrontal signaling during inhibitory control in a salient drug context in cocaine use disorder.

Ceceli A, Parvaz M, King S, Schafer M, Malaker P, Sharma A Cereb Cortex. 2022; 33(3):597-611.

PMID: 35244138 PMC: 9890460. DOI: 10.1093/cercor/bhac087.

Dopamine dysfunction in stimulant use disorders: mechanistic comparisons and implications for treatment.

Kohno M, Dennis L, McCready H, Hoffman W Mol Psychiatry. 2021; 27(1):220-229.

PMID: 34117366 PMC: 8664889. DOI: 10.1038/s41380-021-01180-4.

Shifts in the neurobiological mechanisms motivating cocaine use with the development of an addiction-like phenotype in male rats.

Lynch W, Bakhti-Suroosh A, Abel J, Davis C Psychopharmacology (Berl). 2020; 238(3):811-823.

PMID: 33241478 PMC: 8290931. DOI: 10.1007/s00213-020-05732-4.

References

Kleven M, Perry B, Woolverton W, Seiden L . Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res. 1990; 532(1-2):265-70. DOI: 10.1016/0006-8993(90)91768-c. View

Woods R, Cherry S, Mazziotta J . Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr. 1992; 16(4):620-33. DOI: 10.1097/00004728-199207000-00024. View

Milivojevic N, Krisch I, Sket D, Zivin M . The dopamine D1 receptor agonist and D2 receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats. Naunyn Schmiedebergs Arch Pharmacol. 2004; 369(6):576-82. DOI: 10.1007/s00210-004-0937-2. View

Khroyan T, Platt D, Rowlett J, Spealman R . Attenuation of relapse to cocaine seeking by dopamine D1 receptor agonists and antagonists in non-human primates. Psychopharmacology (Berl). 2003; 168(1-2):124-131. DOI: 10.1007/s00213-002-1365-y. View

Abi-Dargham A, Martinez D, Mawlawi O, Simpson N, Hwang D, Slifstein M . Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility. J Cereb Blood Flow Metab. 2000; 20(2):225-43. DOI: 10.1097/00004647-200002000-00003. View

Alleweireldt A, Weber S, Kirschner K, Bullock B, Neisewander J . Blockade or stimulation of D1 dopamine receptors attenuates cue reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl). 2002; 159(3):284-93. DOI: 10.1007/s002130100904. View

Khroyan T, Rowlett J, Spealman R . Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists. J Pharmacol Exp Ther. 2000; 294(2):680-7. View

Farfel G, Kleven M, Woolverton W, Seiden L, Perry B . Effects of repeated injections of cocaine on catecholamine receptor binding sites, dopamine transporter binding sites and behavior in rhesus monkey. Brain Res. 1992; 578(1-2):235-43. DOI: 10.1016/0006-8993(92)90252-5. View

Mintun M, Raichle M, Kilbourn M, Wooten G, Welch M . A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol. 1984; 15(3):217-27. DOI: 10.1002/ana.410150302. View

10.

Halldin C, Foged C, Chou Y, Karlsson P, Swahn C, Sandell J . Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med. 1998; 39(12):2061-8. View

11.

Nader M, Daunais J, Moore T, Nader S, Moore R, Smith H . Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology. 2002; 27(1):35-46. DOI: 10.1016/S0893-133X(01)00427-4. View

12.

Haney M, Ward A, Foltin R, FISCHMAN M . Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl). 2001; 155(4):330-7. DOI: 10.1007/s002130100725. View

13.

Mutschler N, Bergman J . Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl). 2002; 160(4):362-70. DOI: 10.1007/s00213-001-0976-z. View

14.

Self D, Belluzzi J, Kossuth S, Stein L . Self-administration of the D1 agonist SKF 82958 is mediated by D1, not D2, receptors. Psychopharmacology (Berl). 1996; 123(4):303-6. DOI: 10.1007/BF02246638. View

15.

Self D, Barnhart W, Lehman D, Nestler E . Opposite modulation of cocaine-seeking behavior by D1- and D2-like dopamine receptor agonists. Science. 1996; 271(5255):1586-9. DOI: 10.1126/science.271.5255.1586. View

16.

Dias C, Lachize S, Boilet V, Huitelec E, Cador M . Differential effects of dopaminergic agents on locomotor sensitisation and on the reinstatement of cocaine-seeking and food-seeking behaviour. Psychopharmacology (Berl). 2004; 175(4):414-27. DOI: 10.1007/s00213-004-1839-1. View

17.

Ventura A, Sibley D . Altered regulation of the D(1) dopamine receptor in mutant Chinese hamster ovary cells deficient in cyclic AMP-dependent protein kinase activity. J Pharmacol Exp Ther. 2000; 293(2):426-34. View

18.

Shaham Y, Shalev U, Lu L, de Wit H, Stewart J . The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl). 2002; 168(1-2):3-20. DOI: 10.1007/s00213-002-1224-x. View

19.

Bachtell R, Whisler K, Karanian D, Self D . Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat. Psychopharmacology (Berl). 2005; 183(1):41-53. DOI: 10.1007/s00213-005-0133-1. View

20.

Katz J, Witkin J . Selective effects of the D1 dopamine receptor agonist, SKF 38393, on behavior maintained by cocaine injection in squirrel monkeys. Psychopharmacology (Berl). 1992; 109(1-2):241-4. DOI: 10.1007/BF02245508. View